ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Business deals

Quadria Capital looks to exit from Indonesian drugmaker: sources

Carlye Group said to be sole bidder for 30% stake in Soho Global Health

Soho Global Health produces generics, natural medicines, medical devices and consumer products.   © Reuters

SINGAPORE/JAKARTA -- Quadria Capital is in late-stage talks with a global private equity firm to sell its stake in Indonesian pharmaceutical company Soho Global Health, sources familiar with the development told DealStreetAsia.

The health care-focused equity firm, which operates out of Singapore and New Delhi, has been approached by a slew of investors, including CVC Capital Partners, General Atlantic and the Carlyle Group.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more